Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dfca1501abd693c5c11f7371d8759ae |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 |
filingDate |
2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a358cefe6e4ecf4ebc57f8ded8030a7c |
publicationDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20190135175-A |
titleOfInvention |
A drug for treating pharyngitis and its preparation method |
abstract |
The present invention discloses a medicament for treating a sore throat and a method of making the same. The agent for treating the sore throat is 5-18 parts by weight of Rhizoma anemarrhenae, 10-25 parts by weight of Pinellia ternate, 13-20 parts by weight of Rehmannia glutinosa, Ligusticum chuanxiong Hort 12-20 Parts by weight and 5-15 parts by weight of radix (Radix glycyrrhizae). The medicament for treating a sore throat according to the present invention has different constituents as compared to the conventional medicament, and thus can overcome the drawbacks of the conventional medicament. |
priorityDate |
2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |